Impeding U.S. generic drug use criticized

April 19, 2006

Moves by branded drug companies to slow the spread of U.S. generic drugs has been criticized by a pharmacy benefit managers' organization.

"There's an agenda to prevent generics from getting to the market as soon as they could," said Mark Merritt, president of the Pharmaceutical Care Management Association.

There are an unprecedented number of top-selling drugs scheduled to go off patent within five years, and the organization said branded drug companies are creating hurdles to potential savings of $23 billion to seniors and the Medicare system.

The association identified 14 drugs commonly used by older people that are set to go off patent by 2010, including the cholesterol drugs Zocor and Pravachol, the antidepressant Zoloft and the prostate medication Proscar.

Under federal legislation passed in 1984, drug makers have 20 years after discovery of a drug to sell it exclusively, but some drug companies are lobbying for longer patent exclusivity.

"Many of the branded companies have pretty empty pipelines, with few big blockbusters on the horizon," Merritt said. "So they're fighting to keep their current big sellers free of competition."

Copyright 2006 by United Press International

Explore further: Researchers design and patent graphene biosensors

Related Stories

Researchers design and patent graphene biosensors

November 13, 2015

The Moscow Institute of Physics and Technology (MIPT) is patenting biosensor chips based on graphene, graphene oxide and carbon nanotubes that will improve the analysis of biochemical reactions and accelerate the development ...

Recommended for you

'Material universe' yields surprising new particle

November 25, 2015

An international team of researchers has predicted the existence of a new type of particle called the type-II Weyl fermion in metallic materials. When subjected to a magnetic field, the materials containing the particle act ...

CERN collides heavy nuclei at new record high energy

November 25, 2015

The world's most powerful accelerator, the 27 km long Large Hadron Collider (LHC) operating at CERN in Geneva established collisions between lead nuclei, this morning, at the highest energies ever. The LHC has been colliding ...

New gene map reveals cancer's Achilles heel

November 25, 2015

Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.

A blue, neptune-size exoplanet around a red dwarf star

November 25, 2015

A team of astronomers have used the LCOGT network to detect light scattered by tiny particles (called Rayleigh scattering), through the atmosphere of a Neptune-size transiting exoplanet. This suggests a blue sky on this world ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.